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Abstract: This study investigated the effectiveness of Chinese therapeutic food on female reproductive hormones in a double-blind, 
placebo-controlled clinical trial. Chinese kiwi fruit extract (Hong En No. 1) was provided for Australian peri-menopausal women 
for one month. Chinese medical assessment and urinary 2-hydroxyestrone (2-OHE) and 16alpha-hydroxyestrone (16alpha-OHE) 
tests were conducted. Twenty-six urinary samples (pre and post-trial) which met the requirement of testing were analysed, the ratio 
2-OHE:16alpha-OHE of pre-trial (1.18 ± 0.34) and post-trial (0.97 ± 0.29) in the control group (n = 6) decreased but showed no   significant 
change, this ratio of pre-trial (1.44 ± 0.16) and post-trial (1.65 ± 0.21) in the treatment group (n = 7) indicated an improvement (P = 0.066), 
which results in beneficial hormone regulation. The Chinese medicine assessment indicated that the   patterns of disharmony mainly 
include Liver Qi stagnation and Liver-Kidney Yin deficiency patterns. No significant change observed in the control group, significant 
score reduction of the patterns of disharmony was achieved at post-trial in the treatment group, which indicates an improvement of 
general health condition.
Keywords: Chinese therapeutic food, Chinese kiwi fruit, reproductive hormones, 2-hydroxyestrone:16α-hydroxyestrone, Chinese 
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Background
Hormonal fluctuations are known to affect the quality 
of  life  at  different  stages  in  the  human  lifespan. 
In middle-aged peri-menopausal women, hormonal 
fluctuations  are  specifically  known  to  impact  both 
mental  and  physical  health.  Sometimes  the  health 
outcomes  eventuate  in  severe  diseases  for  many 
women, eg, breast cancer, coronary heart disease and 
osteoporosis.
Treatments  for  hormonally-related  diseases  are 
available from both Western and Chinese perspectives. 
While there is a great deal of commonly shared ground 
between  Western  and  Chinese  medicine,  the  main 
difference between them is that diagnosis in Chinese 
medicine relies on patterns of disharmony or dysfunction 
of the organ systems and then aims to match the pattern 
of disharmony to observable pathophysiological change 
rather than explaining causes based solely in terms of 
pathophysiological malfunction.
This  study  investigated  the  Chinese  medicine 
patterns  presented  in  this  peri-menopausal  group 
and the effectiveness of the selected Chinese food—
Chinese kiwi fruit extract on the regulation of the 
biomarker  2-hydroxyestrone:16α-hydroxyestrone. 
The outcomes were compared with a similar study 
conducted previously.
chinese Medicine patterns  
of Disharmony
In Chinese medicine, female hormonal related dis-
eases are related to the Liver meridian. In menstrual 
  disorders,  Liver  meridian  and  Kidney  meridian 
functions are important factors.1 During the   fourteenth 
century, Dr Dan-Xi Zhu summarised that a woman, 
who was worried and depressed, would suffer from 
an accumulation of stagnation. The stagnation would 
be the cause of Spleen Qi deficiency, the Liver Qi 
  rebels horizontally and the stagnation finally turns 
into    nodules.1  The  selected  Chinese  food  extract, 
can nourish yin and clear heat which may resolve 
the symptoms mentioned above (which prevent an 
unwanted change in hormonal levels) and improve 
the quality of women’s lives.2,3
Comparisons  between  modern  diagnostic  meth-
ods  (eg,  bio-marker  tests)  and  Chinese  medicine 
diagnostic methods indicate that Liver Qi stagnation 
and Liver-Kidney Yin deficiency may be the two main 
patterns of pre-clinical changes in the breast.4
Female Reproductive Hormones
Female  reproductive  hormones  have  an  important 
role  in  hormonally  related  breast  cancer  growth.5 
Endocrine  therapy  has  been  developed  based  on 
the  hormone  and  cancer  relationship,  for  example 
the oestrogen receptor blocker, tamoxifen, has been 
widely used.6 Breast cancer oestrogen receptor (ER) 
status is useful in predicting benefits from endocrine 
therapy.7
In  spite  of  the  benefit  of  oestrogen  receptor 
blockers for breast cancer treatment, modern research 
has investigated oestrogen specific pathways, which 
are involved in oestrogen metabolism and play a role 
in the aetiology of breast cancer.8 A large population 
based  case  control  study  has  been  used  to  assess 
the association of the urinary oestrogen metabolites 
2-hydroxyestrone (2-OHE) and 16α-hydroxyestrone 
(16α-OHE)  and  their  ratio  in  breast  cancer.9  The 
mean of 2-OHE:16α-OHE ratio is reported at 1.6:1 in 
42 postmenopausal patients and in the breast cancer 
patient is reported at 0.71:1.10 Studies indicate 2-OHE 
is a weak acting oestrogen, non-genotoxic and has 
an antiestrogen effect.11,12 In Lewis’ research,13 16α-
OHE has been found as a potent oestrogen which 
is  capable  of  accelerating  cell  cycle  kinetics  and 
stimulating the expression of cell cycle regulatory 
proteins. Lewis also stated that 16α-OHE is a potent 
stimulator of DNA synthesis in ER-positive breast 
cancer cells.13
In view of the above, a high level of 16α-OHE 
will stimulate the ER-positive breast cancer growth 
and  a  high  ratio  of  2-OHE:16α-OHE  may  be  of 
benefit to reduce breast cancer incidence. The ratio of 
2-OHE:16α-OHE has also been used as a biomarker 
for breast cancer in clinical trials.14,15
chinese Kiwi Fruit extract
Chinese herbal formulae and food therapy have long 
been used to effectively regulate endocrinal disorders in 
Chinese clinical practice.1,2 One Chinese food therapy 
of interest is the Chinese food extract—Chinese kiwi 
fruit drink, Kiwi fruit (Actinidia chinensis) is rich in 
vitamin C, vitamin E, vitamin K, folate, antithetic 
acid, niacin, lutein, zeaxanthin, arytenoids, falconoid, chinese therapeutic food and reproductive hormones
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calcium,  iron,  manganese,  selenium,  zinc,  copper, 
potassium and magnesium, fibre and amino acids.16,17 
The  selected  extract  contains  polysaccharides, 
multiple  kinds  of  organic  acids,  isoflavones  and 
adequate  amounts  of  trace  elements,  all  of  which 
have been previously used to increase the bio-marker 
2-OHE:16α-OHE.2,18 This extract is used to improve 
the quality of life of women suffering from endocrine 
disorders.19 Research indicates that Kiwi fruit itself 
may be a potential therapeutic product for preventing 
cancer.16,20–22
The Chinese kiwi fruit extract contains isoflavones 
which  are  categorised  as  phytoestrogens.  Their 
functions  are  different  to  oestrogen22  and  the 
isoflavones  will  not  cause  side  effects  like  those 
commonly  attributed  to  hormone  replacement 
therapy. A cohort study found that the therapy, which 
combined  oestrogen  with  progestin,  was  associated 
with an increased risk of breast cancer, stroke, venous 
thromboembolic disease and heart disease.23 Isoflavone 
can increase the ratio of 2-OHE:16α-OHE and reduce 
the risk of breast cancer.12
The Chinese kiwi fruit extract was investigated in 
a series of laboratory, animal and human studies and 
found to have anti-mutagenic, anti-carcinogenic, anti-
oxidant, anti-atherogenic and anti-toxicity effects, as 
well as assisting in DNA repair and stimulating the 
immune system.24
Methods
Fourteen middle aged women responded to newspaper 
advertisements  and  were  recruited  as  participants 
of this study at Victoria University according to the 
following criteria: female, Melbourne resident; aged 
from 40 to 55 (not experiencing amenorrhoea over 
two years). Criteria for applicant exclusion:
•	 Pregnant or breast feeding
•	 Positive mammogram or ultrasound diagnosis of 
breast cancer
•	 Undertaking hormone therapy or taking any form 
of contraceptive pills
•	 Taking  tamoxifen  or  undergoing  chemotherapy 
after surgical treatment of breast cancer
•	 Suffering from liver and/or kidney disease
•	 Being post-menopausal or experiencing amenor-
rhoea over two years
•	 Food allergy or history of intolerance to kiwi fruit
•	 Suffering  from  a  major  chronic  disorder  which 
required of taking medications
The selected Chinese therapeutic food is a wild 
resourced Chinese kiwi fruit extract (Hong En No. 
1, also known as Hong En Health Drink) in powder 
form,  provided  by  Professor  Houen  Xu  of  Peking 
University.  This  extract  meets  the  requirement  of 
providing  therapeutic  efficient  3-OH  isoflavones, 
extracted by ethanol-water extraction method.
In  this  double-blind,  placebo-controlled  clinical 
trial,  the  participants  were  randomly  assigned  into 
treatment (taking the Chinese kiwi fruit extract) and 
control group (taking placebo) using numbered order 
as they became available. The group assignments were 
kept blind from the participants and data collectors.
Participants in treatment group took 10 g powder 
each time, twice a day, mixed with 100 ml warm water.24 
The selected dosage was recommended by a number 
of  Chinese  medicine  practitioners  and  laboratory 
experiments.3,19  The  powder  was  administered  one 
hour before meals (breakfast and dinner), over a one 
month period.
Chinese  medicine  assessment  involved  standard 
Chinese  medicine  diagnostic  procedures25  which 
include questioning of symptoms, checking of pulse 
and  observing  the  tongue  of  the  participants  by 
two registered Chinese medicine practitioners. The 
symptoms and signs in relation to Liver Qi Stagnation 
including: anger, stress, abdominal bloating, excessive 
dreams, irregular menstruation, bitter taste in mouth 
and wiry pulse; The symptoms and signs in relation 
to Liver-Kidney Yin deficiency including: lower back 
pain, weak knee, hot flushes, tinnitus, night sweating, 
scanty  menstruation,  dry  throat,  red  tongue,  less 
tongue coating, thin and rapid pulse. The collected 
symptoms  and  signs  were  matched  to  patterns  of 
disharmony,  using  the  0–10  scale  (agreeable  by 
the  practitioners).  The  scores  represent  the  levels 
of disharmony from 0 to a maximum of 10. Scores 
between  1–5  are  recognised  as  minor  patterns  of 
disharmony,  while  those  between  6–10  are  severe 
patterns of disharmony.
2-OHE:16α-OHE urine test used the ESTRAMET 
Urinary  Estrogen  Metabolite  Kit  (from  IMMUNA 
CARE  Corporation),  which  is  a  competitive, Fu and Xu
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    solid-phase  enzyme  immunoassays.18  The  collected 
urine samples at the pre and post-trial were analysed. 
Procedures  follow  the  requirement  of  the  Urinary 
Estrogen  Metabolite  Kit.  Urinary  oestrogen  is 
ordinarily measured normalized according to urinary 
creatinine concentration in units of nanograms, which 
is the ratio of oestrogen to per mg creatinine. The 
correlation  of  ESTRAMET  2-OHE  and  16α-OHE 
versus  these  metabolites  by  Gas  Chromatography-
Mass Spectroscopy (GCMS) method were greater than 
0.94.26 Data were analysed using t-test by SPSS 18.
The study was approved by the relative committee 
and the ethics approval was gained from the Human 
Research Ethics Committee of Victoria University, 
Australia. All  participants  received  an  explanation 
document and a consent form for completion.
Results and Discussion
Thirteen  participants  completed  all  the  tests,  one 
withdrew  due  to  other  health  condition.  Twenty-
six urinary samples (pre and post-trial) which met 
the requirement of testing were analysed, the ratio 
2-OHE:16α-OHE  of  pre-trial  (1.18  ±  0.34)  and 
post-trial (0.97 ± 0.29) in the control group (n = 6) 
decreased but showed no significant change, this ratio 
of pre-trial (1.44 ± 0.16) and post-trial (1.65 ± 0.21) in 
the treatment group (n = 7) indicated an improvement 
(P  =  0.066),  which  results  in  beneficial  hormone 
regulation  (See  Table  1).  The  Chinese  medicine 
assessment indicated that the patterns of disharmony 
mainly include Liver Qi stagnation and Liver-Kidney 
Yin deficiency patterns. Significant score reduction of 
the patterns of disharmony was achieved at post-trial 
in the treatment group, no significant change observed 
in the control group (See Table 2).
Chinese  medicine  assessment  indicated  that  the 
participants  felt  correspondingly  weaker  and  their 
health  conditions  also  had  adverse  trends  in  their 
middle age. They commonly had mood swings which 
relates  to  Liver  Qi  stagnation.1  Peri-menopausal 
symptoms also affected their daily life. Data collected 
from these participants at this stage of testing indi-
cated that the adverse symptoms and relative signs 
changed after the treatment resulting in the levels of 
disharmony being reduced.
The results of this study have further approved a 
similar conclusion to a previous pilot study, with six 
Chinese menopausal women, who were administered 
100 ml Hong En No. 1 drink for two days. Their urine 
sample ratio of 2-OHE:16α-OHE was elevated by the 
intake of this drink.24 After a two day period of usage, 
16α-OHE  had  reduced  significantly  that  benefit 
women’s health.
In a previous clinical trial,3 thirty-nine participants, 
who  were  diagnosed  with  cancer  and  had  just 
completed  chemotherapy,  were  given  this  drink 
(equal  to  20 g  of  Hong  En  No.  1)  daily  over  a 
seven day period. The results indicated the rate 
of binucleate lymphocyte cells with micronuclei 
in these participants had significantly decreased. 
This  may  indicate  the  recovery  of  chromosome 
change.3
According  to  Bradlow18  the  urine  2-OHE:16α-
OHE  ratio  is  stable  over  the  menstrual  cycle  of 
women  who  have  not  taken  oral  contraceptives. 
The results gained from these studies demonstrate a 
reliable outcome which using 2-OHE:16α-OHE as a 
biomarker to evaluate the effectiveness of the selected 
Chinese therapeutic food on reproductive hormone. 
These results indicated that Chinese kiwi fruit extract 
can  benefit  the  reproductive  hormones  for  middle 
aged women, therefore reduce the risk of hormone 
fluctuation related diseases.
After the completion of the trial, it was shown that 
the changes of patterns of disharmony indicated in 
the Chinese medicine assessment are relevant to the 
Table 1. The effects of chinese kiwi fruit extract on urinary 2Ohe:16α-Ohe of peri-menopausal women.*
Groups Age pre-trial 2OHe:16α-OHe post-trial 2OHe:16α-OHe
Treatment 
(n = 7)
 
47.71 ± 4.68
 
1.44 ± 0.16
 
1.65 ± 0.21**
control 
(n = 6)
 
48.33 ± 6.71
 
1.18 ± 0.34
 
0.97 ± 0.29
notes: *Participants take chinese kiwi fruit extract (hong en no. 1) 10 g ×	2/days ×	4weeks; **P = 0.066, t = 2.244.chinese therapeutic food and reproductive hormones
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change of biomedical markers, which may be useful in 
western-medical assessment of hormones fluctuation 
and pre-clinical breast diseases. If Chinese medicine 
diagnostic methods indicate that Liver Qi stagnation 
and Liver-Kidney Yin deficiency are the main patterns 
of middle aged women hormone fluctuation or pre-
clinical breast diseases, it is reasonable to argue that 
the treatment principle should be based on regulat-
ing Qi and nourishing Yin. This study has provided 
a repeatable evidence of using the Chinese kiwi fruit 
extract for the regulation of hormonal disorder and 
Chinese medicine patterns of disharmony.
conclusions
In this study, the patterns of disharmony for a group 
of middle aged Australian women presented reflect 
the Chinese medicine theory that Liver Qi stagnation 
and Liver-Kidney Yin deficiency are the main patterns 
for this group. The bio markers used in this study are 
both reliable and sensitive in order to investigate the 
hormone  imbalance.  The  selection  of  the  Chinese 
therapeutic  food—Chinese  kiwi  fruit  extract  could 
benefit those concerned with peri-menopausal symp-
toms or diseases associated with hormone disorders 
and treat the patterns of disharmony.
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